Our serum test is the first preeclampsia-specific test that can be used to stratify patients into low- or high-risk categories, indicating whether a patient is at risk for developing preeclampsia with severe features.
Skip to Content MayoACCESS MayoLINK...
New tests launched in March - Insights
In March 2022, Mayo Clinic Laboratories announced eighteen new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
Peripheral neuropathy - Insights
Learn about our peripheral neuropathy testing to identify autoimmune and genetic causes of the condition.
Yuma Regional Medical Center: Strategic expansion to serve a growing community - Insights
Faced with a population increase and the need to expand both laboratory testing capacity and capabilities, Yuma Regional Medical Center leaned into its relationship with Mayo Clinic Laboratories to gain insights to strengthen community...
Cayuga Medical Center: Building a world-class lab that drives revenue - Insights
Cayuga Medical Center sought to challenge the narrative that a hospital’s lab is an expensive liability by positioning themselves as the laboratory of choice in their area.
Cutting-edge lab work cracks a medical mystery: Kenneth Hobby - Insights
Kenneth Hobby assumed his fever, fatigue, and aching pains in May 2018 were from another bout of malaria. He was on one of his frequent visits to Zambia in southern Africa, where the mosquito-borne parasite is common. But anti-malaria drugs...
Hot Topic Archives - Page 4 of 6 - Insights
Skip to Content MayoACCESS MayoLINK...
Future Direction of Lab Medicine - Insights
Looking into the future of laboratory medicine and pathology and providing insight into the direction its heading.
GFAP: Novel Test for a Newly Identified Meningoencephalomyelitis - Insights
Mayo Clinic Laboratories is the only laboratory in the world to offer testing for a novel form of autoimmune meningoencephalomyelitis. Known as autoimmune glial fibrillary acidic protein (GFAP) astrocytopathy, the condition was identified...